Does low vitamin B12 raise homocysteine and cause macrocytosis?

Vitamin B12 (cobalamin) is a fundamental metabolic cofactor crucial for maintaining cellular homeostasis, nucleotide synthesis, and amino acid metabolism.

Molecular mechanisms

• Enzymatic function: In its active coenzyme form, methylcobalamin, vitamin B12 acts as an obligate cofactor for methionine synthase. During catalysis, a zinc-activated homocysteine thiolate attacks the methyl group of methylcobalamin to produce methionine. The resulting highly nucleophilic cob(I)alamin state is remethylated by N5-methyltetrahydrofolate to regenerate the active cofactor.
• The methyl-folate trap: A deficiency in B12 traps folate as 5-methyltetrahydrofolate, halting the regeneration of tetrahydrofolate (THF) needed for de novo thymidylate (dTMP) synthesis.
• Nuclear-cytoplasmic asynchrony: Impaired dTMP synthesis disrupts DNA replication and causes strand fragmentation in bone marrow precursors. While nuclear division is arrested, cytoplasmic maturation and hemoglobin accumulation proceed normally, driving the development of large, macrocytic red blood cells.

Clinical and metabolic effects

• Homocysteine accumulation: Impaired remethylation causes intracellular homocysteine to accumulate and leak into plasma. A meta-analysis of 21 randomized controlled trials (RCTs) showed that vitamin B12 supplementation reduces plasma homocysteine by a pooled weighted mean difference of approximately 4.15 µmol/L (most effective at doses >500 µg/day for 12+ weeks). However, clinical trials show this correction does not translate to reduced cardiovascular or thromboembolic risks.
• Macrocytosis expression: Though highly prevalent (60% to 80%) in macrocytic cohorts, elevated mean corpuscular volume (MCV) occurs in only 10% to 30% of biochemically B12-deficient patients due to masking by concurrent iron deficiency or inflammation. Following cobalamin therapy, MCV begins to decrease in 10 to 14 days and normalizes within 8 weeks.

Bottom line

• Vitamin B12 is an indispensable cofactor for methionine synthase-mediated remethylation. Deficiency blocks this metabolic junction, accumulating homocysteine and driving macrocytosis via the methyl-folate trap—both of which are highly responsive to targeted cobalamin replenishment.